Modulatory effect of a complex fraction derived from colostrum on fibroblast contractibility and consequences on...

Area of Science:

• Biochemistry
• Dermatology
• Wound Healing Research

Background:

• Colostrum-derived whey contains complex compounds with potential therapeutic applications.
• Wound healing involves intricate processes including contraction and remodeling.
• Fibroblast-mediated collagen gel contraction is a key in vitro model for studying wound healing dynamics.

Purpose of the Study:

• To investigate the wound healing properties of a complex compound (immune (IM) fraction) from colostrum-derived whey.
• To evaluate the in vitro and in vivo effects of the IM fraction on wound contraction and remodeling.

Main Methods:

• In vitro: Assessed collagen gel contraction inhibition and fibroblast stress fiber formation.
• In vivo: Utilized two guinea pig wound models (full-thickness wounds and scar tissue treatment).
• Evaluated wound closure, scar formation, tissue area, collagen deposition, and α-smooth muscle actin expression.

Main Results:

• The IM fraction dose-dependently inhibited collagen gel contraction in vitro without affecting fibroblast density or stress fibers.
• In vivo, liquid IM fraction delayed wound closure by contraction in full-thickness wounds.
• Gel formulation of IM fraction minimized scar formation in 5/8 wounds and reduced hypertrophic scarring compared to controls.

Conclusions:

• The IM fraction exhibits wound healing properties by modulating fibroblast-mediated contraction.
• It may influence wound remodeling and reduce scar tissue formation.
• Further research into the IM fraction's therapeutic potential for wound management is warranted.